sj-pdf-1-tam-10.1177_1758835920985632 – Supplemental material for Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer

Rocca, Andrea; Cortesi, Pietro; Cortesi, Laura; Gianni, Lorenzo; Matteucci, Federica; Fantini, Lorenzo; Maestri, Antonio; Giunchi, Donata Casadei; Cavanna, Luigi; Ciani, Rosa; Falcini, Fabio; Bagni, Antonella; Meldoli, Elena; Dall’Agata, Monia; Volpi, Roberta; Andreis, Daniele; Nanni, Oriana; Curcio, Annalisa; Lucchi, Leonardo; Amadori, Dino; Fedeli, Anna

doi:10.25384/SAGE.13857372.v1

sj-pdf-1-tam-10.1177_1758835920985632.pdf (47.69 kB)

sj-pdf-1-tam-10.1177_1758835920985632 – Supplemental material for Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer

journal contribution

posted on 2021-02-10, 13:09 authored by Andrea Rocca, Pietro Cortesi, Laura Cortesi, Lorenzo Gianni, Federica Matteucci, Lorenzo Fantini, Antonio Maestri, Donata Casadei Giunchi, Luigi Cavanna, Rosa Ciani, Fabio Falcini, Antonella Bagni, Elena Meldoli, Monia Dall’Agata, Roberta Volpi, Daniele Andreis, Oriana Nanni, Annalisa Curcio, Leonardo Lucchi, Dino Amadori, Anna Fedeli

Supplemental material, sj-pdf-1-tam-10.1177_1758835920985632 for Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer by Andrea Rocca, Pietro Cortesi, Laura Cortesi, Lorenzo Gianni, Federica Matteucci, Lorenzo Fantini, Antonio Maestri, Donata Casadei Giunchi, Luigi Cavanna, Rosa Ciani, Fabio Falcini, Antonella Bagni, Elena Meldoli, Monia Dall’Agata, Roberta Volpi, Daniele Andreis, Oriana Nanni, Annalisa Curcio, Leonardo Lucchi, Dino Amadori and Anna Fedeli in Therapeutic Advances in Medical Oncology